Final chord of the EU-project Smart SMEs - 31/05/2021 Building a sustainable network for natural fibre-based SMEs in the Alpine Space The European project Smart SMEs came successfully to its end in May 2021 with the final conference, which attracted participants from different parts of Europe. https://www.bio-pro.de/en/information/press-release/building-sustainable-network-natural-fibre-based-smes-alpine-space
Final chord of the EU-project Smart SMEs - 31/05/2021 Building a sustainable network for natural fibre-based SMEs in the Alpine Space The European project Smart SMEs came successfully to its end in May 2021 with the final conference, which attracted participants from different parts of Europe. https://www.biooekonomie-bw.de/en/articles/pm/building-sustainable-network-natural-fibre-based-smes-alpine-space
Zero Bullshit Company - 31/05/2021 From being thrown away to becoming a recycled product - Stuttgart start-up produces healthy snacks Throwing away food? The Stuttgart-based start-up Zero Bullshit Company is declaring war on food wastage by making nutrient-rich products largely from food industry leftovers. The three food technologists who created this transparent brand are looking to develop more than just delicious and nutritious products.https://www.biooekonomie-bw.de/en/articles/news/being-thrown-away-becoming-recycled-product-stuttgart-start-produces-healthy-snacks
Article - 31/05/2021 Tracking down tumour-associated pain in pancreatic cancer Pancreatic cancer comes along quietly: unnoticed for a long time, it often triggers excruciating pain as the tumour progresses. This pain is associated with cancer cells invading pancreatic nerves. Dr. Michael Hirth from Mannheim University Hospital has shed some light on the complex communication between cancer cells and nerve cells. His findings could eventually be used for personalised pain therapies.https://www.gesundheitsindustrie-bw.de/en/article/news/tracking-down-tumour-associated-pain-pancreatic-cancer
Digitalisation of the healthcare system Photon-Counting (PC)-CT Consortium Installing the next digital generation of computed tomography at various Baden-Württemberg medical centres (PC3)https://www.bio-pro.de/en/activities/healthcare-industry/photon-counting-pc-ct-consortium
Pooling competencies MDR & IVDR Competence Centre BW (MIK) https://www.bio-pro.de/en/activities/healthcare-industry/mdr-ivdr-competence-centre-bw
Press release - 27/05/2021 Coffee´s pulp waste becomes organic compost The pulp of coffee beans is considered a waste product on coffee plantations, which is usually thrown away or dumped into rivers - with significant negative consequences for climate change and the environment. Macarena San Martín-Ruiz from the University of Stuttgart is working with Coopetarrazú, the largest coffee cooperative in Costa Rica, to find out how the mixture of pulp and husks can be turned into organic compost and thus protect the…https://www.biooekonomie-bw.de/en/articles/pm/coffee-s-pulp-waste-becomes-organic-compost
Press release - 26/05/2021 Memetis continues its path to become a technology leader in Shape Memory driven miniature valving – Fluid-o-Tech S.r.l. invests an undisclosed amount to support memetis’ growth and development The Deep-Tech Start-Up memetis GmbH from Germany, which produces the world’s most compact and lightest commercially available valves driven by shape memory alloys, announces a new partnership with Fluid-o-Tech S.r.l., an Italian innovation and market leader in the field of fluid-pumps. https://www.gesundheitsindustrie-bw.de/en/article/press-release/memetis-continues-its-path-become-technology-leader-shape-memory-driven-miniature-valving-fluid-o-tech-srl-invests-undisclosed-a
Press release - 25/05/2021 From harmless skin bacteria to dreaded pathogens The bacterium Staphylococcus epidermidisis primarily a harmless microbe found on the skin and in the noses of humans. Yet some strains of this species can cause infections – in catheters, artificial joints, heart valves, and in the bloodstream – which are difficult to treat. These bacteria are often resistant to a particularly effective antibiotic, methicillin, and are among the most feared germs in hospitals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/harmless-skin-bacteria-dreaded-pathogens
Press release - 25/05/2021 How “paralyzed” immune cells can be reactivated against brain tumors Brain tumor cells with a certain common mutation reprogram invading immune cells. This leads to the paralysis of the body's immune defense against the tumor in the brain. Researchers from Heidelberg, Mannheim, and Freiburg discovered this mechanism and at the same time identified a way of reactivating the paralyzed immune system to fight the tumor.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-paralyzed-immune-cells-can-be-reactivated-against-brain-tumors
Vaccine development - 25/05/2021 Vaccines - a beacon of hope in the fight against pandemics Having long been considered less lucrative for the big pharmaceutical companies, vaccine development is taking off in an unforeseen way in the wake of the COVID-19 pandemic. Financial support is flooding in and all kinds of vaccine development strategies are being deployed. Among the winners in the competition for effective coronavirus vaccines are vaccines based on RNA technology.https://www.gesundheitsindustrie-bw.de/en/article/dossier/vaccines-beacon-hope-fight-against-pandemics
BIOPRO is the central point of contact for all matters relating to the life sciences General Projects https://www.bio-pro.de/en/projects/general-projects
Baden-Württemberg is the number one health region in Germany Current projects https://www.bio-pro.de/en/projects/current-projects
Health Data Scenarios Health Data Scenarios Data generated by the healthcare system has enormous potential for improving the quality of patient-centered care. As part of the Health Data Scenarios project, Basel Area Business & Innovation worked with numerous experts from industry and academia in 2020 to develop ten scenarios of what future health data ecosystems could look like. These scenarios are now being discussed and validated together with experts and opinion leaders from…https://www.bio-pro.de/en/projects/Completed-projects/health-data-scenarios
Press release - 18/05/2021 BBI JU to invest €104.5 million into circular bio-based projects The Bio-based Industries Joint Undertaking (BBI JU) has signed the grant agreements with 18 new projects, selected for funding under the 2020 Call for proposals. 199 beneficiaries from 26 countries across the EU and beyond will receive BBI JU’s financial support worth €104.5 million. This is the seventh and last BBI JU call which will bring the total investment of the initiative to €821.6 million and the BBI JU’s portfolio to 142 projects. https://www.biooekonomie-bw.de/en/articles/pm/bbi-ju-invest-eur1045-million-circular-bio-based-projects
Signal mechanisms in inflammatory processes - 18/05/2021 Newly discovered substances activate the inflammasome in macrophages Low-grade chronic inflammation caused by components of the innate immune system may increase the risk of developing a variety of diseases in the long term. In their search for the signalling mechanisms underlying these inflammatory processes, Prof. Dr. Olaf Groß' research group at the Freiburg University Medical Centre discovered new active substances with immunostimulatory properties that may open up additional possibilities in cancer…https://www.gesundheitsindustrie-bw.de/en/article/news/newly-discovered-substances-activate-inflammasome-macrophages
Press release - 17/05/2021 New findings in genome research The working group around Dr. Philipp Rathert at the Institute for Biochemistry and Technical Biochemistry investigates the regulation of epigenetic networks of certain cancers and ways of treating them. The working group published its new findings in April. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-genome-research
Press release - 03/05/2021 Bioactive paper coatings to replace plastic for packaging foods The amount of plastic waste increases every year. Some of this waste is due to plastic packaging used to protect food. As part of the “BioActiveMaterials” project, researchers at the Fraunhofer-Gesellschaft have developed an eco-friendly coating for paper packaging. With this, not only is plastic saved, but the coating of plant-based proteins and waxes also extends the shelf life of the food.https://www.biooekonomie-bw.de/en/articles/pm/bioactive-paper-coatings-replace-plastic-packaging-foods
Press release - 30/04/2021 More veg, less dairy Freiburg researchers have studied how changing their diet could influence the ecological footprint of Germans.https://www.biooekonomie-bw.de/en/articles/pm/more-veg-less-dairy
Article - 29/04/2021 Nanobodies for determining neutralising antibodies after corona infection After contact with a pathogen, ideally our immune system generates neutralising antibodies to prevent a future infection. With NeutrobodyPlex, scientists from Reutlingen and Tübingen have developed a highly specific test procedure based on single-domain antibodies (nanobodies) that can be used to easily and reliably determine the quality of the immune response against the novel coronavirus.https://www.gesundheitsindustrie-bw.de/en/article/news/nanobodies-determining-neutralising-antibodies-after-corona-infection
Press release - 23/04/2021 The Amazing Field of Science: Bioeconomy to End the Ecological Crisis Population growth and the increasing standard of living make our society face big ecological challenges: Climate change, littering of the seas, dwindling agricultural areas, resource scarcity. Bioeconomy aims at replacing fossil by regenerative resources and at using advanced and sustainable technologies based on biological knowledge and principles.https://www.biooekonomie-bw.de/en/articles/pm/amazing-field-science-bioeconomy-end-ecological-crisis
Press release - 23/04/2021 For which plastic products is biodegradation a viable endof- life option? The BioSinn project found products and applications for which biodegradation at the end-of-life is a real option. 25 fact sheets answer technical and regulatory questions for each application. The market volume of these applications was also estimated: in Germany it is about 170,000 tonnes, in the European Union about 1 million tonnes per year!https://www.biooekonomie-bw.de/en/articles/pm/bei-welchen-kunststoffprodukten-ist-der-biologische-abbau-eine-sinnvolle-end-life-option
Press release - 21/04/2021 A study identifies the top 50 life and biological sciences and technologies driving innovation in the bio-based sectors in Europe. The study “Life and Biological Sciences and Technologies as Engines for Bio-based Innovation”, funded by the European Commission, DG Research and Innovation has been published and is now available for download from the website of the Publications Office of the European Union.https://www.biooekonomie-bw.de/en/articles/pm/study-identifies-top-50-life-and-biological-sciences-and-technologies-driving-innovation-bio-based-sectors-europe
Press release - 21/04/2021 Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding Atriva Therapeutics GmbH, a company that is pioneering the development of therapies for the treatment of viral infections, has secured up to €11.4 million in federal funding. The company, founded in 2015, announced today that it was selected for research funding from the German Federal Ministry of Education and Research (BMBF). Atriva will use the funds to advance its drug ATR-002 towards market maturity as quickly as possible.https://www.gesundheitsindustrie-bw.de/en/article/press-release/atriva-therapeutics-kann-dank-foerdermitteln-covid-19-medikament-schneller-entwickeln
Press release - 20/04/2021 Cellulose fibers against climate change Protecting the global climate is an undertaking that presents both industry and society with a major task. It will not be possible to achieve the climate targets simply by limiting global emissions, by saving carbon dioxide (CO2). This is because there will continue to be unavoidable CO2 emissions that will nevertheless have to be compensated. https://www.biooekonomie-bw.de/en/articles/pm/cellulosefasern-gegen-den-klimawandel
Press release - 14/04/2021 Engineering T cells for cancer therapy efficiently and safely Genetically enhancing a patient's immune cells by adding therapeutic genes to them outside the body is regarded as a promising new treatment approach in oncology. However, the production of these therapeutic cells using viruses is not only expensive but time-consuming. Researchers at the German Cancer Research Center (DKFZ) have developed an innovative non-viral vector that can efficiently introduce therapeutic genes into immune cells. https://www.gesundheitsindustrie-bw.de/en/article/press-release/engineering-t-cells-cancer-therapy-efficiently-and-safely
Article - 14/04/2021 Calling for quality seal for implants Today's seniors are older and more active, which is why implants remain in the body longer and are subjected to greater strain than before. Improved surfaces are expected to ensure that the implants heal and integrate into the bone optimally. In an interview with BIOPRO, Dietmar Schaffarczyk, CEO of Konstanz-based stimOS GmbH, explains why a voluntary quality seal makes sense and gives consumers a better chance of recognising high-quality…https://www.gesundheitsindustrie-bw.de/en/article/news/calling-quality-seal-implants
Press release - 13/04/2021 Evotec’s BRIDGE “beLAB2122” leverages academic innovation from our region Evotec SE announced today the launch of beLAB2122 in the Rhine- Main-Neckar region to efficiently advance first-in-class therapeutic concepts into investable drug discovery projects. Mediated and supported by BioRN, Evotec’s newest BRIDGE brings together the European Molecular Biology Laboratory (“EMBL”), the German Cancer Research Center (“DKFZ”), the Goethe University Frankfurt, Heidelberg University and the University of Tübingen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/evotecs-bridge-belab2122-leverages-academic-innovation-our-region
Press release - 08/04/2021 How to enhance innovative value chains in the bioeconomy in the Alpine Space? The European Interreg project AlpLinkBioEco in comes April 2021 to a successful end. The final conference of the project was conducted on the 31st of March 2021 and attracted over 160 participants from different parts of Europe. AlpLinkBioEco, of which BIOPRO Baden-Württemberg is a partner, has been running for three years (2018-2021) as part of the EU-Strategy for the Alpine Region (EUSALP).https://www.bio-pro.de/en/information/press-release/how-enhance-innovative-value-chains-bioeconomy-alpine-space
Quantum Technology Ulm - 08/04/2021 Diamonds for life sciences innovations The world's first commercial quantum computer,’IBM Q System One’, is now in operation in Ehningen near Stuttgart. This is a major leap forward in quantum technology in Germany. It marks the point at which conventional computers reach their limits. The University of Ulm is involved in three of six collaborative projects being funded by the Baden-Württemberg Ministry of Economic Affairs, Labour and Housing Construction.https://www.gesundheitsindustrie-bw.de/en/article/news/diamonds-life-sciences-innovations
Alternative source of protein - 07/04/2021 Smart insect farms as sustainable protein sources of the future It is estimated that by 2050, if not before, the world's population will have grown so much that it will be difficult to provide adequate supplies of food for everyone. It is therefore high time to look for alternatives. One option could be insects as an environmentally friendly source of protein for humans and animals. The start-up company Cepri is developing smart insect farms with the goal to make primary production, which is not yet…https://www.biooekonomie-bw.de/en/articles/news/smart-insect-farms-sustainable-protein-sources-future
Press release - 06/04/2021 Showcase Bioeconomy: Industrial crops make unproductive farmland profitable European project with participation of the University of Hohenheim investigates how unprofitable fields can be used sustainably while adding value with renewable raw materials.https://www.biooekonomie-bw.de/en/articles/pm/schaufenster-biooekonomie-industriepflanzen-machen-unproduktives-ackerland-rentabel
Press release - 01/04/2021 Joint Masterplan on bioeconomy in the Alpine macro-region unveiled AlpLinkBioEco Interreg project presents one of its main results. https://www.bio-pro.de/en/information/press-release/joint-masterplan-bioeconomy-alpine-macro-region-unveiled
Press release - 30/03/2021 Celonic and CureVac announce agreement to manufacture over 100 million doses of CureVac's Covid-19 vaccine candidate, CVnCoV CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on mRNA and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization specializing in the development and production of Advanced Therapy Medicinal Products and mammalian cell line-expressed bio-therapeutics, announced their partnership for the production of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV.https://www.gesundheitsindustrie-bw.de/en/article/press-release/celonic-and-curevac-announce-agreement-manufacture-over-100-million-doses-curevacs-covid-19-vaccine-candidate-cvncov
Event - 01/07/2021 Meet & Match 2021 – Microbiome Online, Registration deadline: 17/06/2021, Meet & Match https://www.bio-pro.de/en/events/past-events/meet-match-2021-microbiome
Press release - 24/03/2021 Vaccination against mutated protein tested in brain tumor patients for the first time Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors.https://www.gesundheitsindustrie-bw.de/en/article/press-release/vaccination-against-mutated-protein-tested-brain-tumor-patients-first-time
Press release - 24/03/2021 Liver cancer: which patients benefit from immunotherapy? Immunotherapy using checkpoint inhibitors is effective in around a quarter of patients with liver cancer. However, to date, physicians have been unable to predict which patients would benefit from this type of treatment and which would not. Researchers from the German Cancer Research Center have now discovered that liver cancer caused by chronic inflammatory fatty liver disease does not respond to this treatment. On the contrary: in an…https://www.gesundheitsindustrie-bw.de/en/article/press-release/liver-cancer-which-patients-benefit-immunotherapy
Microfluidics in medical technology - 24/03/2021 Ultra-compact: valves with shape memory actuators Karlsruhe-based company memetis shows that this is possible. Intelligent components for controlling fluids open up huge potential in the medical technology and biotechnology sectors - from vaccine development and cell line analysis to drug research and point-of-care solutions.https://www.gesundheitsindustrie-bw.de/en/article/news/ultra-compact-valves-shape-memory-actuators
Press release - 23/03/2021 AFYREN and Südzucker reach long term deal to supply factory producing biobased organic acids AFYREN secures procurement of sugar beet co-products, major feedstock for industrial- scale production of its sustainable chemicals.https://www.biooekonomie-bw.de/en/articles/pm/afyren-and-sudzucker-reach-long-term-deal-supply-factory-producing-biobased-organic-acids
Press release - 23/03/2021 CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced the publication of preclinical data demonstrating that their COVID-19 vaccine candidate, CVnCoV, protects against challenge infections with the SARS-CoV-2 Variant of Concern B.1.351 and a strain of the original SARS-CoV-2 B1 lineage (BavPat1) in a transgenic mouse model.https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevacs-covid-19-vaccine-candidate-cvncov-demonstrates-protection-against-sars-cov-2-b1351-variant-south-african-variant-precli
Press release - 19/03/2021 New single-cell analysis of leucemic stem cells A new method allows stem cells and cancer stem cells to be studied at the single cell level and the resulting cell clones to be traced directly. Studying thousands of individual cells in parallel, the researchers combined the analysis of the genomic cancer mutations with the associated expression profiles.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-single-cell-analysis-leucemic-stem-cells
Press release - 18/03/2021 DBFZ presents exensively expanded online database on biogenic raw materials Systematically prepared and easily accessible research data can provide an essential basis for decision-making for a wide range of stakeholders from politics, science and industry. The resource database developed by the DBFZ, which contains a wealth of information on various biomass potentials and their current use, has been extensively expanded and is now also available in two languages (DE/EN) with a variety of new functionalities.https://www.biooekonomie-bw.de/en/articles/pm/dbfz-presents-exensively-expanded-online-database-biogenic-raw-materials
Article - 17/03/2021 Epigenetic switches in bacteria as biosensors The analysis of pathogen biomarkers and biomarkers for the diagnosis of diseases can be crucial for health. However, the detection of pathogens and diseases depends on a sensitive and reliable method that delivers rapid results. Biosensors have such properties. Researchers at the Institute of Biochemistry and Technical Biochemistry (IBTB) at Stuttgart University have constructed an epigenetic circuit composed of plasmids that might make it…https://www.gesundheitsindustrie-bw.de/en/article/news/epigenetic-switches-bacteria-biosensors
Press release - 15/03/2021 How novel pathogens may cause the development of colorectal cancer Do BMMFs, the novel infectious agents found in dairy products and bovine sera, play a role in the development of colorectal cancer? Scientists led by Harald zur Hausen detected the pathogens in colorectal cancer patients in close proximity to tumors. The researchers show that the BMMFs trigger local chronic inflammation, which can cause mutations via activated oxygen molecules and thus promote cancer development in the long term.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-novel-pathogens-may-cause-development-colorectal-cancer
Press release - 11/03/2021 Researchers recommend earlier start of breast cancer screening with family history of ovarian cancer Women have an increased risk of breast cancer if they have a family history of this disease. However, the risk may also be higher if first-degree family members have another type of cancer, according to a study by a team of scientists and physicians from the National Center for Tumor Diseases (NCT) Heidelberg, the German Cancer Research Center (DKFZ) and Heidelberg University Hospital (UKHD), as well as international colleagues. https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-recommend-earlier-start-breast-cancer-screening-family-history-ovarian-cancer
Article - 10/03/2021 Faster to single cells using miniature grinder Tissue cells are needed for medical diagnostics, cell therapies and tissue engineering, among other things. A novel tissue grinder gently and automatically dissociates cells from tissue. In November 2020, the newly founded biotech company Fast Forward Discoveries GmbH (FFX) delivered its first tissue grinders to customers.https://www.gesundheitsindustrie-bw.de/en/article/news/faster-single-cells-using-miniature-grinder
Paper technology - 10/03/2021 PLAFCO – a sustainable plastic substitute made from paper Plastic is indispensable: it is cheap and practical and found in many disposable products such as drinking straws, disposable tableware or even packaging like bonded beverage cartons or bags – and it has a disastrous effect on the environment. The start-up company Plafco Fibertech Oy has developed a sustainable plastic substitute made of paper that could replace many disposable plastic products in the future.https://www.biooekonomie-bw.de/en/articles/news/plafco-sustainable-plastic-substitute-made-paper
Press release - 04/03/2021 CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Novartis AG announced today that they have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the start of production, technology transfers and test runs are already underway. https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-novartis-sign-initial-agreement-manufacturing-covid-19-vaccine-candidate-cvncov
Press release - 04/03/2021 Induced pluripotent stem cells reveal causes of disease Induced pluripotent stem cells (iPSC) are suitable for discovering the genes that underly complex and also rare genetic diseases. Scientists from the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL), together with international partners, have studied genotype-phenotype relationships in iPSCs using data from approximately one thousand donors.https://www.gesundheitsindustrie-bw.de/en/article/press-release/induced-pluripotent-stem-cells-reveal-causes-disease
Press release - 03/03/2021 New Baden-Württemberg network to reduce animal experiments A new network has been set up in Baden-Württemberg aimed at reducing animal experiments as well as further improving animal welfare. It combines new approaches and measures at the state’s biomedical research locations, which are expected to limit stress in laboratory animals and steadily reduce the number of animals used in research in line with the 3R principles of Replacement, Reduction, and Refinement.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-baden-wuerttemberg-network-reduce-animal-experiments
Expert interview - 03/03/2021 Healthcare movers – the future of Baden-Württemberg's healthcare industry The 'Healthcare Movers 2020 - Baden-Württemberg Report' reveals the potentials and challenges Baden-Württemberg healthcare companies encounter as the digital transformation of the healthcare market progresses. In an interview with Dr. Ariane Pott from BIOPRO, the authors of the report, Beatus Hofrichter and Dr. Ursula Kramer, explain what is required to take the major step towards becoming a digital avant-garde company.https://www.gesundheitsindustrie-bw.de/en/article/news/healthcare-movers-future-baden-wuerttembergs-healthcare-industry
Press release - 01/03/2021 Vegetable proteins replace petroleum-based raw materials https://www.biooekonomie-bw.de/en/articles/pm/vegetable-proteins-replace-petroleum-based-raw-materials
Press release - 26/02/2021 European Parliament report recognizes potential role of bioplastics in the circular economy On 8 February, the European Parliament adopted its Own Initiative Report on the Circular Economy which recognised the role of bioplastics for the future. Amongst other issues highlighted, the MEPs emphasised the potential role of bio–based and biodegradable and compostable plastics in the circular economy whilst noting that bio-based and/or biodegradable plastics alone will not provide a solution to the environmental concerns related to plastics.https://www.biooekonomie-bw.de/en/articles/pm/european-parliament-report-recognizes-potential-role-bioplastics-circular-economy
Exploit opportunities, mastering challenges Post-Brexit https://www.bio-pro.de/en/projects/current-projects/post-brexit
Press release - 24/02/2021 Supposedly "silent" mutation with serious consequences So-called silent mutations have no effect on the composition of a protein. They are therefore not considered to promote cancer. However, scientists from the German Consortium for Translational Cancer Research (DKTK), partner site Essen, now describe in a case of kidney cancer an overlooked silent mutation with a major impact on prognosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/supposedly-silent-mutation-serious-consequences
Press release - 24/02/2021 Disease progression in childhood cancer: Lengthening of telomeres promotes relapse Neuroblastoma can spread relentlessly or shrink spontaneously. Scientists from the Hopp Children’s Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the University of Heidelberg and the National Center for Tumor Diseases (NCT) Heidelberg have shown that some malignant neuroblastomas employ a trick to avoid cell death: they use a special mechanism to lengthen the telomeres at the end of their chromosomes. https://www.gesundheitsindustrie-bw.de/en/article/press-release/disease-progression-childhood-cancer-lengthening-telomeres-promotes-relapse
Press release - 23/02/2021 Commission gives the green light to the successor of BBI JU The European Commission agreed on the successor of BBI JU – the Circular Bio-based Europe Joint Undertaking (CBE JU) in a legislative proposal adopted today. The new partnership between the EU and the Bio-based Industries Consortium (BIC) is expected to build on the success of BBI JU while stepping up its contribution to the EU’s climate targets, in line with the European Green Deal. The European Parliament and Council will now study the…https://www.biooekonomie-bw.de/en/articles/pm/commission-gives-green-light-successor-bbi-ju
Press release - 22/02/2021 Dual Yield on Arable Land: Guideline for Agrivoltaics Published Agrivoltaics enables the dual use of arable land: Photovoltaic modules, which are mounted on a structure, generate renewable electricity and underneath agricultural crops grow. The approach increases land efficiency and could mitigate conflicts over the use of arable land in the future. A new guideline provides up-to-date information on the technology, its potential and the current state of development. https://www.biooekonomie-bw.de/en/articles/pm/Dual-Yield-on-Arable-Land-Guideline-for-Agrivoltaics-Published
Press release - 17/02/2021 A new piece of the HIV infection puzzle explored Researchers from EMBL and Heidelberg University Hospital combine high-resolution imaging to observe the infection process in cell nuclei, opening the door for new therapeutics.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-piece-hiv-infection-puzzle-explored
Article - 17/02/2021 Whole blood model enables development of early warning system for sepsis Sepsis is a life-threatening disease that can be treated all the more successfully the faster therapy is initiated. It is not just the infection itself that is so dangerous, but a dysregulated response of the immune system. Physicians at Ulm University Hospital have now developed an animal-free test system that can be used to research the disease and develop innovative diagnostic tools to quickly assess a patient's sepsis risk and optimise…https://www.gesundheitsindustrie-bw.de/en/article/news/whole-blood-model-enables-development-early-warning-system-sepsis
Overview MDR & IVDR Fast-Track Support BW https://www.bio-pro.de/en/projects/Completed-projects/mdr-ivdr-fast-track-support-bw
Press release - 09/02/2021 New rapid test to detect coronavirus antibodies developed An international research team involving the universities of Paraná and Tübingen has developed a rapid test that can reliably identify Covid-19 antibodies in the blood within minutes. As the researchers report in the journal ACS Sensors, the new process is based on a simple measuring principle making it easy to carry out without expensive instruments, and is therefore suitable for use at mobile testing centers or by laboratories.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-rapid-test-detect-coronavirus-antibodies-developed
Zentrales Branchentreffen - 16/09/2021 Forum Healthcare industry 2021 Freiburg & online, Kongress/Symposium https://www.bio-pro.de/en/events/forum-2021
Press release - 08/02/2021 Water-repellent and more: coating textiles sustainably with chitosan Textiles can be coated with the biopolymer chitosan and thus made water-repellent by binding hydrophobic molecules. The good thing is that this can also replace toxic and petroleum-based substances that are currently used for textile finishing. In the last few years Fraunhofer IGB and partners have developed technology to provide fibers with the desired properties using biotechnological processes and chitosan.https://www.biooekonomie-bw.de/en/articles/pm/Water-repellent-and-more-coating-textiles-sustainably-with-chitosan
AI application potential & Matchmaking - 22/04/2021 - 06/05/2021 Application Potential of Artificial Intelligence in the Pharmaceutical Industry Onlinehttps://www.bio-pro.de/en/events/past-events/ki-in-der-pharmaindustrie
Press release - 05/02/2021 Showcase Bioeconomy: Intelligent Robot Helps Preserve Orchard Meadows University of Hohenheim project contributes to maintaining valuable biotopes: Autonomous robot to help prune fruit trees so they stay healthy.https://www.biooekonomie-bw.de/en/articles/pm/Showcase-Bioeconomy-Intelligent-Robot-Helps-Preserve-Orchard-Meadows
From field to socket - 03/02/2021 Energy park & Donau-Silphie: a symbiosis that benefits nature Biogas plants that produce non-fossil fuels are very much in vogue at the moment. In the Swabian hamlet of Hahnennest, four family farms have joined forces to form an energy park and operate a local biogas plant, covering everything from substrate production to the sale of energy. https://www.biooekonomie-bw.de/en/articles/news/Energy-park-Donau-Silphie-a-symbiosis-that-benefits-nature
Press release - 02/02/2021 Cyanobacteria could revolutionize the plastic industry Microbiologists at the University of Tübingen modify bacteria to produce climate-neutral and rapidly degradable bioplastics.https://www.biooekonomie-bw.de/en/articles/pm/Cyanobacteria-could-revolutionize-the-plastic-industry
Press release - 01/02/2021 Targeting a rapid market breakthrough for new vaccine production method In a so-called inactivated or killed vaccine, the virus particles it contains are first rendered inactive by means of the toxic chemical formaldehyde. A better way of achieving this, however, is to irradiate the pathogens with low-energy electrons. Four Fraunhofer Institutes have now developed a new method of vaccine production based on this technique that is not only quicker but also guarantees a higher quality of product. https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeting-rapid-market-breakthrough-new-vaccine-production-method
Press release - 29/01/2021 The added value of compostable plastics for the circular economy For quite some time now, the European Commission (EC) is putting a special focus on biodegradable and compostable polymers when assessing the general role of bioplastics. https://www.biooekonomie-bw.de/en/articles/pm/added-value-compostable-plastics-circular-economy
Press release - 28/01/2021 Carl Zeiss Foundation funds Interdisciplinary practice Study at Heidelberg University with the sum of approximately of 4.5 Million Euros Can interconnected digital assistance systems enhance the quality of life of people in older age? Scientists in an interdisciplinary research project at Heidelberg University are exploring this question in a representative practice study. The participating researchers want to investigate how well these technical aids can be used and what benefit they achieve.https://www.gesundheitsindustrie-bw.de/en/article/press-release/carl-zeiss-foundation-funds-interdisciplinary-practice-study-heidelberg-university-sum-approximately-45-million-euros
Press release - 26/01/2021 Report on the Mapping of Biomass Value Chains for Improved Sustainable Energy use in the Baltic Sea Region Countries Published The University of Warmia and Mazury in Olsztyn, Polish partner of the BalticBiomass4Value project, published a report which maps biomass value chains for improved sustainable energy use in the Baltic Sea Region countries. The research focuses on the 9 Baltic Sea Region (BSR) countries: Denmark, Germany, Estonia, Finland, Latvia, Lithuania, Poland, Sweden, and Norway.https://www.biooekonomie-bw.de/en/articles/pm/report-mapping-biomass-value-chains-improved-sustainable-energy-use-baltic-sea-region-countries-published
Event - 05/02/2021 Startup Funding Day online, Informationsveranstaltung https://www.bio-pro.de/en/events/past-events/startup-funding-day
Press release - 25/01/2021 Protein anchors as a newly discovered key molecule in cancer spread and epilepsy Certain anchor proteins inhibit a key metabolic driver that plays an important role in cancer and developmental brain disorders. Scientists from the German Cancer Research Center (DKFZ) and the University of Innsbruck, together with a Europe-wide research network, discovered this molecular mechanism, which could open up new opportunities for personalized therapies for cancer and neuronal diseases. They published their results in the journal Cell.https://www.gesundheitsindustrie-bw.de/en/article/press-release/protein-anchors-newly-discovered-key-molecule-cancer-spread-and-epilepsy
Event - 16/02/2021 Alpine Policy Forum online (Cisco Webex), Registration deadline: 09/02/2021, Kongress/Symposium https://www.bio-pro.de/en/events/past-events/alpine-policy-forum